My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry.

    Ferrara A, Karter AJ, Ackerson LM, Liu JY, Selby JV; Northern California Kaiser Permanente Diabetes Registry.

    Diabetes Care. 2001 Jul;24(7):1144-50.PMID: 11423493 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of postmenopausal hormone replacement therapy on HbA(1c) levels.

    Okada M, Nomura S, Ikoma Y, Yamamoto E, Ito T, Mitsui T, Tamakoshi K, Mizutani S.

    Diabetes Care. 2003 Apr;26(4):1088-92.PMID: 12663578 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hormone replacement therapy and glucose tolerance in EPIC-Norfolk: a population-based study.

    Sargeant LA, Wareham NJ, Khaw KT.

    Diabetes Metab Res Rev. 2000 Jan-Feb;16(1):20-5.PMID: 10707035 [PubMed - indexed for MEDLINE]Related articles

    4.

    Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.

    Harris MI; National Health and Nutrition Examination Survey (NHANES III).

    Diabetes Care. 2001 Jun;24(6):979-82.PMID: 11375356 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

    Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC; Diabetes Outcomes in Veterans Study (DOVES).

    Diabetes Care. 2003 Jun;26(6):1759-63.PMID: 12766106 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Abdominal obesity and ethnic differences in diabetes awareness, treatment, and glycemic control.

    Okosun IS, Dever GE.

    Obes Res. 2002 Dec;10(12):1241-50.PMID: 12490668 [PubMed - indexed for MEDLINE]Related articles

    7.

    Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry.

    Karter AJ, Ackerson LM, Darbinian JA, D'Agostino RB Jr, Ferrara A, Liu J, Selby JV.

    Am J Med. 2001 Jul;111(1):1-9.PMID: 11448654 [PubMed - indexed for MEDLINE]Related articles

    8.

    Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

    Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

    Diabetes Care. 2001 Jul;24(7):1167-74.PMID: 11423497 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    10.

    Distribution of HbA(1c) levels for children and young adults in the U.S.: Third National Health and Nutrition Examination Survey.

    Saaddine JB, Fagot-Campagna A, Rolka D, Narayan KM, Geiss L, Eberhardt M, Flegal KM.

    Diabetes Care. 2002 Aug;25(8):1326-30.PMID: 12145229 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    12.

    The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

    Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

    Diabetes Care. 2002 Jan;25(1):9-15.PMID: 11772894 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Racial differences in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition Study.

    de Rekeneire N, Rooks RN, Simonsick EM, Shorr RI, Kuller LH, Schwartz AV, Harris TB; Health, Aging and Body Composition Study.

    Diabetes Care. 2003 Jul;26(7):1986-92. Erratum in: Diabetes Care. 2003 Dec;26(12):3368. PMID: 12832300 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Racial and ethnic differences in glycemic control of adults with type 2 diabetes.

    Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS.

    Diabetes Care. 1999 Mar;22(3):403-8.PMID: 10097918 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

    Luis Bautista J, Bugos C, Dirnberger G, Atherton T.

    Clin Ther. 2003 Jan;25(1):194-209.PMID: 12637120 [PubMed - indexed for MEDLINE]Related articles

    16.

    How well do patients' assessments of their diabetes self-management correlate with actual glycemic control and receipt of recommended diabetes services?

    Heisler M, Smith DM, Hayward RA, Krein SL, Kerr EA.

    Diabetes Care. 2003 Mar;26(3):738-43.PMID: 12610031 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.

    Davidson JA, McMorn SO, Waterhouse BR, Cobitz AR.

    Clin Ther. 2007 Sep;29(9):1900-14.PMID: 18035190 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mechanisms for racial and ethnic disparities in glycemic control in middle-aged and older Americans in the health and retirement study.

    Heisler M, Faul JD, Hayward RA, Langa KM, Blaum C, Weir D.

    Arch Intern Med. 2007 Sep 24;167(17):1853-60.PMID: 17893306 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset.

    Hillier TA, Pedula KL.

    Diabetes Care. 2001 Sep;24(9):1522-7.PMID: 11522693 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.

    Yurgin N, Secnik K, Lage MJ.

    Clin Ther. 2007 Feb;29(2):316-25.PMID: 17472823 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity